FDA Inspection 816978 — Scott D. Segal

Scott D. Segal — FEI 3009621431

The FDA completed an inspection of Scott D. Segal on Jan 18, 2013 in North Miami, FL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Jan 18, 2013
Fiscal Year
2013
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
North Miami, FL (United States)

Additional Details

Clinical Investigator (CI)